MetaPathogen.com/Epstein-Barr Virus (EBV)/References

 

Abstract image
Abstract image

Please help keeping these websites open for everybody as long as possible

 

Epstein-Barr Virus (EBV)

Print

References

  1. Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 2004 Oct 1;70(7):1279-87.
  2. Yamashita N, Kimura H, Morishima T. Virological aspects of Epstein-Barr virus infections. Acta Med Okayama. 2005 Dec;59(6):239-46.
  3. Hutt-Fletcher LM. Epstein-Barr virus entry. J Virol. 2007 Aug;81(15):7825-32.
  4. Ascherio A. Epstein-Barr virus in the development of multiple sclerosis. Expert Rev Neurother. 2008 Mar;8(3):331-3.
  5. Gulley ML, Tang W. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn. 2008 Jul;10(4):279-92.
  6. Heslop HE. How I treat EBV lymphoproliferation. Blood. 2009 Nov 5;114(19):4002-8.
  7. Duca KA et al. A virtual look at Epstein-Barr virus infection: biological interpretations. PLoS Pathog. 2007 Oct 19;3(10):1388-400.
  8. God JM, Haque A. Burkitt lymphoma: pathogenesis and immune evasion. J Oncol. 2010;2010. pii: 516047.
  9. Eligio P, Delia R, Valeria G. EBV Chronic Infections. Mediterr J Hematol Infect Dis. 2010 Aug 10;2(1).
  10. Massini G, Siemer D, Hohaus S. EBV in Hodgkin Lymphoma. Mediterr J Hematol Infect Dis. 2009 Nov 24;1(2).
  11. Fox CP, Shannon-Lowe C, Rowe M. Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations. Herpesviridae. 2011 Sep 7;2:8.
  12. Odumade OA, Hogquist KA, Balfour HH Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011 Jan;24(1):193-209.
  13. Hardie DR. Human gamma-herpesviruses: a review of 2 divergent paths to oncogenesis. Transfus Apher Sci. 2010 Apr;42(2):177-83.
  14. Bornkamm GW, Hammerschmidt W. Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):437-59.
  15. Johannsen E et al. Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16286-91.
  16. Thorley-Lawson DA, Duca KA, Shapiro M. Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality. Trends Immunol. 2008 Apr;29(4):195-201.
  17. Clemens MJ. Epstein-Barr virus: inhibition of apoptosis as a mechanism of cell transformation. Int J Biochem Cell Biol. 2006 Feb;38(2):164-9.
  18. Crawford DH. Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):461-73.
  19. Hardie DR. Human gamma-herpesviruses: a review of 2 divergent paths to oncogenesis. Transfus Apher Sci. 2010 Apr;42(2):177-83.
  20. Münz C, Moormann A. Immune escape by Epstein-Barr virus associated malignancies. Semin Cancer Biol. 2008 Dec;18(6):381-7.
  21. Ning S. Innate immune modulation in EBV infection. Herpesviridae. 2011 Jan 5;2(1):1.
  22. Kutok JL, Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol. 2006;1:375-404.
  23. Vetsika EK, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med. 2004 Nov 5;6(23):1-16.
  24. Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010 May 27;362(21):1993-2000.
  25. Rowe M, Zuo J. Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity. Microbes Infect. 2010 Mar;12(3):173-81.
  26. Vereide D, Sugden B. Proof for EBV's sustaining role in Burkitt's lymphomas. Semin Cancer Biol. 2009 Dec;19(6):389-93.
  27. Rowe M, Kelly GL, Bell AI, Rickinson AB. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin Cancer Biol. 2009 Dec;19(6):377-88.
  28. Gruhne B, Kamranvar SA, Masucci MG, Sompallae R. EBV and genomic instability--a new look at the role of the virus in the pathogenesis of Burkitt's lymphoma. Semin Cancer Biol. 2009 Dec;19(6):394-400.
  29. Suzuki M, Hinuma Y. Evaluation of Epstein-Barr virus-associated nuclear antigen with various human cell lines. Int J Cancer. 1974 Dec 15;14(6):753-61.
  30. Villegas E, Santiago O, Sorlózano A, Gutierrez J. New strategies and patent therapeutics in EBV-associated diseases. Mini Rev Med Chem. 2010 Sep;10(10):914-27.
  31. Villegas E, Santiago O, Sorlózano A, Gutierrez J. New strategies and patent therapeutics in EBV-associated diseases. Mini Rev Med Chem. 2010 Sep;10(10):914-27.
  32. Khan G. Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma? Exp Hematol. 2006 Apr;34(4):399-406.
  33. Hammerschmidt W, Sugden B. Epstein-Barr virus sustains Burkitt's lymphomas and Hodgkin's disease. Trends Mol Med. 2004 Jul;10(7):331-6.
  34. Kapatai G, Murray P. Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol. 2007 Dec;60(12):1342-9.
  35. Ambinder RF. Epstein-barr virus and hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2007:204-9.
  36. Münz C, Moormann A. Immune escape by Epstein-Barr virus associated malignancies. Semin Cancer Biol. 2008 Dec;18(6):381-7.
  37. Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol. 2004 May;125(3):267-81.
  38. Carbone A, Spina M, Gloghini A, Tirelli U. Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome. Am J Hematol. 2011 Feb;86(2):170-9.
  39. Landgren O, Caporaso NE. New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphoma. Hematol Oncol Clin North Am. 2007 Oct;21(5):825-40.
  40. Kennedy-Nasser AA, Hanley P, Bollard CM. Hodgkin disease and the role of the immune system. Pediatr Hematol Oncol. 2011 Apr;28(3):176-86.
Back to top Nemose

Queries

Back to top Nemose